Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million Dec 10, 2018 Life Science
WuXi Biologics Announced Exclusive Discovery Research with Brii Biosciences for Novel Bispecific Antibody Immunotherapeutics Dec 10, 2018 Life Science
Brii Biosciences Builds Innovative Pipeline, Forges Public-Private Partnerships to Bring Novel Medicines to Chinese Patients Dec 6, 2018 Life Science
WuXi Biologics Commenced Construction of the Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland Dec 5, 2018 Life Science
Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-OX40 Monoclonal Antibody IBI101 Dec 5, 2018 Life Science
HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Genentech Dec 4, 2018 Life Science
Revance Announces China Market License Agreement with Fosun Pharma for RT002 Dec 4, 2018 Life Science
Viracta and Salubris Announce Equity Financing and Partnership to Bring Novel Treatment for Viral-Associated Cancers to China Dec 4, 2018 Life Science
CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection (Trademark: EVOMELA®) Dec 3, 2018 Life Science
